Applied Evidence

Recreational cannabinoid use: The hazards behind the “high”

Author and Disclosure Information

 

References

Potential adverse consequences of cannabis use

Although the potential adverse consequences are vast, the literature on this subject is limited for various reasons:

  • Many studies are observational with a small sample size.
  • Most studies examine smoked cannabis—not other routes of delivery.
  • When smoked, the dose, frequency, duration, and smoking technique are variable.
  • The quantity of Δ-9-tetrahydrocannabinol (THC), the primary psychoactive component in cannabis, is variable. (For more on the chemical properties of the marijuana plant, see “Cannabinoids: A diverse group of chemicals.”7)
  • Most studies do not examine medical users, who are expected to use less cannabis or lower doses of THC.
  • There are confounding effects of other drugs, notably tobacco, which is used by up to 90% of cannabis users.8

Lower quality of life. In general, regular non-medical cannabis use is associated with a lower quality of life and poorer socioeconomic outcomes (TABLE 1).9-12 Physical and mental health is ranked lower by heavy users as compared to extremely low users.9 Some who attempt butane extraction of THC from the plant have experienced explosions and severe burns.13

Quality of life, socioeconomic issues associated with recreational cannabis use image

Studies regarding cannabis use and weight are conflicting. Appetite and weight may increase initially, and young adults who increase their use of the drug are more likely to find themselves on an increasing obesity trajectory.14 However, in an observational study of nearly 11,000 participants ages 20 to 59 years, cannabis users had a lower body mass index, better lipid parameters, and were less likely to have diabetes than non-using counterparts.15

Pages

Recommended Reading

How best to approach urine drug testing (and the one key question to ask)
MDedge Family Medicine
10 tips to mitigate legal risks of opioid prescribing
MDedge Family Medicine
Leveraging what is available
MDedge Family Medicine
Study: Health spending related to opioid treatment rose more than 1,300%
MDedge Family Medicine
FDA panel gives nod to removing boxed warning on varenicline
MDedge Family Medicine
Buprenorphine restrictions don’t hinder addiction therapy
MDedge Family Medicine
Cannabis use after first-episode psychosis may raise relapse risk
MDedge Family Medicine
Best practices discussed for using naloxone
MDedge Family Medicine
Experts: Fewer opioids, more treatment laws mean nothing without better access to care
MDedge Family Medicine
Medication-assisted treatment in group settings may result in greater job satisfaction, more reimbursements
MDedge Family Medicine

Related Articles

  • Applied Evidence

    Medical marijuana: A treatment worth trying?

    With medical marijuana available in more and more states, family physicians need to know what the evidence says about its use. This review...